Related Experiment Videos
"Whack-a-Mole" Treatment Approach to 3G EGFR TKI Progression: Elegant Translational Science but Limited Clinical
Yanyan Hu1, Sai-Hong Ignatius Ou2
1Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, P.R. China; Nanjing Tech University, Nanjing, P.R. China.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Kernel density-encoded MALDI-TOF spectra with LightGBM machine learning for multiplex resistance prediction in Klebsiella pneumoniae.
Diagnostic microbiology and infectious disease·2026
[Corrigendum] Circulating microRNA profiles and the identification of miR‑593 and miR‑511 which directly target the PROP1 gene in children with combined pituitary hormone deficiency.
International journal of molecular medicine·2026
Lachnospiraceae and Its Metabolite Malate Act in Concert to Repair Gut Microbiota Imbalance and Block Colorectal Cancer Progression.
Frontiers in bioscience (Landmark edition)·2026
Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Prognostic Significance of Spread Through Airspaces (STAS) in Stage Ia/bN0 Non-small Cell Lung Cancer - An Evaluation in the JCOG0802/WJOG4607L Clinical Trial Patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Lung Cancer Patient Advocacy Progress and New Challenges Since 2006.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Lung-retentive liposomes via monocyte recruitment for the treatment of acute respiratory distress syndrome.
Journal of controlled release : official journal of the Controlled Release Society·2026
Inhalable biomimetic apoptotic bodies enable targeted LXRα agonist delivery to lung macrophages for acute lung injury therapy.
Colloids and surfaces. B, Biointerfaces·2026
Triple-pathway synergistic senolysis via AKAP1 silencing and calcium overload: An aptamer-functionalized DNAzyme nanoplatform for anti-pulmonary fibrosis research.
Colloids and surfaces. B, Biointerfaces·2026
Mechanical constraints on cell plasticity: insights from the olfactory epithelium.
Frontiers in cell and developmental biology·2026
Macrophage RSAD2 Couples mtDNA Synthesis With a Self-Amplifying Inflammatory Circuit to Orchestrate Tissue Repair.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026